Intensification of Gla-100 with Prandial Insulin: A Stepwise Progression Toward Glycemic Control

Area of Science:

• Endocrinology
• Metabolic Diseases
• Pharmacotherapy

Background:

• Inadequate control of postprandial glucose (PPG) excursions is linked to cardiovascular disease.
• Basal insulins (e.g., insulin glargine 100 U/mL [Gla-100]) provide overall glycemic control but require intensification for effective PPG management.
• Therapy intensification often involves adding prandial insulins to basal therapy.

Purpose of the Study:

• To evaluate the stepwise basal-plus or basal-prandial intensification regimen.
• To compare this approach with conventional basal-bolus or premixed insulin strategies.
• To highlight the advantages of the basal-plus approach for PPG control.

Main Methods:

• Review of recent studies and guidelines on diabetes therapy intensification.
• Comparison of stepwise basal-prandial intensification with conventional methods.
• Analysis of outcomes including glycemic control and hypoglycemic events.

Main Results:

• Stepwise basal-prandial intensification demonstrates comparable glycemic control to conventional approaches.
• This regimen offers advantages such as fewer hypoglycemic events and personalized therapy.
• A simple self-management algorithm facilitates titration.

Conclusions:

• Recent guidelines recommend stepwise basal-prandial intensification over other methods for initiating therapy intensification.
• This approach is preferred by physicians and patients.
• It represents a better alternative to immediate full basal-bolus regimens or premixed insulin use.